JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.
Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback